DURHAM, NC, US - Aug 5, 2019 - Cenduit LLC has announced a Bangalore expansion, as the latest development across the organization’s global operations in Asia Pacific (APAC), North America, and Europe. The move in India solidifies Cenduit’s positioning as the global innovator of IRT (Interactive Response Technology) systems that deliver quantifiable improvements in clinical trial safety, compliance and costs; as well as continuous commitment to delivering operational excellence for customers across APAC.

Cenduit has significantly increased headcount in India to 400+ professionals over several years, with strategic investments and strong demand for its innovative technology and world-class global operations. Positioned for growth, Cenduit has taken prime space at 6th Block in Koramangala, Bangalore.

Cenduit’s scalable ecosystem of technology, processes, and expertise developed over 12+ 

years drives measurable improvements in an increasingly challenging clinical research environment. Cenduit’s consistently groundbreaking, flexible approaches in IRT enable greater efficiencies, meet patient outcomes, ensure compliance, and simplify the site and patient experience for biopharmas of all sizes - regardless of complexity, geography, or indication. 

Cenduit CEO Sam Osman commented, “Cenduit’s strong growth illustrates the biopharma industry’s increasing reliance on our ability to deliver digitized, integrated technology systems that create greater scientific and economic efficiencies for patient outcomes. We’re gratified at the industry’s response to Cenduit’s dedication to quality-first systems and services that meet the needs of this growing market. We look forward to continuing to work with our channel partners worldwide as we sustain robust market expansion.” 

Mr. Osman formally inaugurated the Bangalore office on 18th July 2019, and Bangalore-based Vice President of Operations and site head Jinu Jose hosted a celebration to inaugurate the new office. 

Dr. Ramesh Jagannathan, an experienced clinical research leader, was among the industry leaders who attended the Cenduit inauguration. Dr. Jagannathan touched upon key trends in the clinical trials industry in India, one of the strategic focus areas for biopharma.

Jinu Jose said, “Sponsors, CROs, and sites rely on Cenduit to build trials that meet regulatory requirements and make life easier for sites and patients. We invite our clients and associates to visit us and discuss how Cenduit eClinical System systems and client delivery integrate the vital principles of Operational Excellence for better patient outcomes across enterprise clinical research programs.” (Read Mr. Jose’s Pharma Tech Outlook magazine article, “Industrializing Operational Excellence through Quality, Innovation and Expertise,”here.)

About Cenduit LLC

Cenduit enables clinical study sponsors and CROs to safely, quickly and economically deliver new drugs and therapies that improve and save lives. As the world leader in quality IRT systems, Cenduit accelerates study startup, with clinical supply chain intelligence, deep clinical operations expertise, and client-centric CORE teams. With 500+ experts throughout the US, Europe, and Asia, Cenduit helps clients manage clinical studies in over 100 countries, interacting with over 1,000,000 patients at 33,000 sites. Visit www.cenduit.com for more information.

Become part of the “Cenduit Digital Pack” development or client delivery teams in Bangalore, or at Cenduit locations worldwide, across Asia-Pacific, Europe and North America. View the list of open job postings here.  

Contact:

Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393

Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253